findmyKOL
Clinical trialNCT05873881RecruitingPhase 3Interventional

COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

SponsorHamilton Health Sciences CorporationEnrollment2,500Heart Failure
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Hamilton Health Sciences Corporation

    Hamilton, Ontario, Canada

    Eva Lonn, MDPhil G. Joseph, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jan 2024
Primary completion
30 Jun 2027
Completion
30 Jun 2027
Last update posted
19 Jun 2025
Registered enrollment
2,500
Registry id
NCT05873881
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.